about
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and preventionHost-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strainsVaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirusAre Escherichia coli Pathotypes Still Relevant in the Era of Whole-Genome Sequencing?Immunology of Gut Mucosal VaccinesPart III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984–2005Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine developmentEnterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees.Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.Recent advances in understanding enteric pathogenic Escherichia coli.Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A.DNA phosphorothioation is widespread and quantized in bacterial genomes.Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain.The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates.Volunteer challenge with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and CS19Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteersRefinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.Human Toxoplasma gondii-specific secretory immunoglobulin A reduces T. gondii infection of enterocytes in vitro.Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli.Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneumImpact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans.Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli.Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4.Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection.Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic areaOral immunization of rabbits with enterotoxigenic Escherichia coli protects against intraintestinal challenge.Identification of a new fimbrial structure in enterotoxigenic Escherichia coli (ETEC) serotype O148:H28 which adheres to human intestinal mucosa: a potentially new human ETEC colonization factorConstruction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.Experimental enterotoxin-induced Escherichia coli diarrhea and protection induced by previous infection with bacteria of the same adhesin or enterotoxin type.Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans
P2860
Q24530558-C140733A-97A5-4B0B-B288-74B6D4C893E0Q24654909-B1FEFBE7-666D-4497-84DA-32B599645569Q26995690-1DC8A4B0-8A80-4E72-9EF5-6368242423ADQ28077683-2695D341-4DC1-42D7-AFF0-17E2A3DA17D0Q28972559-55A90D89-0F78-42E1-AC77-F2D57B7FF1EBQ29038412-BE4F097E-B81B-40DE-9B0F-15B9E56B5B56Q30155406-0F74FD41-8907-4C6E-B987-2BD71FDB1D09Q30449794-A874A35D-D631-4728-AA77-DAA4D069E921Q33597022-4DDF227F-1FA5-4DCB-8A4D-94ACFC8C4870Q33628356-4913E525-8464-4697-9924-E894C514009DQ33963134-FEB48B9E-8E52-4795-8252-2D4F8EB30E53Q34002647-1EDE0161-AA18-442E-A7EE-3F51E7E47B03Q34119379-78883BFB-410C-4DCC-B98A-DD6486A25829Q34120919-98186E66-78C4-4A9D-B242-323F12B3267CQ34244632-67D8CECD-4CDF-413E-AD7E-FF9E555BAFBBQ34334202-BFD890A7-41A3-4EAC-8C2A-31AB8ADF0BE2Q34375210-05B6A568-7810-43A8-8361-0D9BE67FA0DEQ34521431-1EEAAB44-C5F3-4F3D-89CB-51C9F0E91B7AQ34582855-8FD9B8F8-CE22-4F2C-A2C0-0834861525D7Q34716080-4FDB7CE2-9674-4533-B4FF-5796CF490216Q34803749-1A47151D-F4FB-468F-A807-1EF2965AED1EQ35016658-74E9CEC4-6E5B-498A-8BA6-00FB60D0C381Q35159544-E88773DD-E273-4596-B309-A2171AC8ECFBQ35271174-920E0B45-1319-47FD-88D1-F79A8EF0876DQ35460555-FAA10157-3755-4902-A425-463D2E271B63Q35614216-937910D8-2C40-4734-BBF0-9AE3161A70D3Q35670969-A92AEA0D-3921-42AA-B782-617A55B7DEF7Q35689012-6CB57ADF-E7F7-4155-98D5-2CCAF07B14B3Q35784104-0DE9FED4-42E2-42E4-AAC9-7BBD31CBE3D8Q36253755-64AF37B7-7D4A-4663-8D13-C4DC4DF06276Q36362257-3E293A6C-0557-40A1-87D0-58004443B819Q36415039-56762738-5104-430A-81B0-11B67121A468Q36439621-66D40363-5B11-4C28-80F2-7D2E825A271DQ36593894-76212B3F-DE27-4D67-A3CC-ACD981B72E73Q36675467-E6944C53-FE2F-4CA6-8730-EF6F39E73206Q36993634-B29B693E-B09B-473E-B88A-99CFBAC136F2Q37014829-AC6E39BB-F0F8-4020-914B-756669AA4D2EQ37042161-5CA83453-9F4A-4A83-AF9F-585821C35C5BQ37053261-8F3EAA6B-96D9-469C-B2AE-94A4B2920034Q37224008-E8C8D8EC-CB8F-497F-9815-552B4399995B
P2860
description
1979 nî lūn-bûn
@nan
1979 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի մարտին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Immunity to enterotoxigenic Escherichia coli.
@ast
Immunity to enterotoxigenic Escherichia coli.
@en
Immunity to enterotoxigenic Escherichia coli.
@nl
type
label
Immunity to enterotoxigenic Escherichia coli.
@ast
Immunity to enterotoxigenic Escherichia coli.
@en
Immunity to enterotoxigenic Escherichia coli.
@nl
prefLabel
Immunity to enterotoxigenic Escherichia coli.
@ast
Immunity to enterotoxigenic Escherichia coli.
@en
Immunity to enterotoxigenic Escherichia coli.
@nl
P2093
P2860
P1476
Immunity to enterotoxigenic Escherichia coli.
@en
P2093
P2860
P304
P407
P577
1979-03-01T00:00:00Z